vs
拜玛林制药（BMRN）与Dave & Buster's Entertainment, Inc.（PLAY）财务数据对比。点击上方公司名可切换其他公司
拜玛林制药的季度营收约是Dave & Buster's Entertainment, Inc.的2.0倍（$874.6M vs $448.2M），拜玛林制药净利率更高（-5.3% vs -9.4%，领先4.1%），拜玛林制药同比增速更快（17.0% vs -1.1%），拜玛林制药自由现金流更多（$58.9M vs $-20.6M），过去两年拜玛林制药的营收复合增速更高（16.1% vs -13.5%）
拜玛林制药是总部位于美国加利福尼亚州圣拉斐尔的生物技术企业，在美洲、亚洲、欧洲多地设有办事机构及生产设施，核心业务聚焦酶替代疗法研发，是全球首个推出Ⅰ型粘多糖贮积症治疗药物拉罗尼酶及苯丙酮尿症治疗药物的企业。
戴夫与巴斯特娱乐是总部位于美国达拉斯的餐饮娱乐企业，旗下每家门店都配备全套服务餐厅、酒吧以及名为“百万美元 midway”的游戏游乐区。截至2024年2月，该公司共开设162家门店，其中美国本土158家，波多黎各和加拿大各设2家门店，主打餐饮与休闲娱乐融合的消费体验。
BMRN vs PLAY — 直观对比
营收规模更大
BMRN
是对方的2.0倍
$448.2M
营收增速更快
BMRN
高出18.1%
-1.1%
净利率更高
BMRN
高出4.1%
-9.4%
自由现金流更多
BMRN
多$79.5M
$-20.6M
两年增速更快
BMRN
近两年复合增速
-13.5%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $874.6M | $448.2M |
| 净利润 | $-46.6M | $-42.1M |
| 毛利率 | 68.5% | 85.8% |
| 营业利润率 | -5.1% | -3.6% |
| 净利率 | -5.3% | -9.4% |
| 营收同比 | 17.0% | -1.1% |
| 净利润同比 | -137.3% | -28.7% |
| 每股收益（稀释后） | $-0.22 | $-1.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BMRNPLAY
| Q4 25 | $874.6M | $448.2M | ||
| Q3 25 | $776.1M | $557.4M | ||
| Q2 25 | $825.4M | $567.7M | ||
| Q1 25 | $745.1M | $534.5M | ||
| Q4 24 | $747.3M | $453.0M | ||
| Q3 24 | $745.7M | $557.1M | ||
| Q2 24 | $712.0M | $588.1M | ||
| Q1 24 | $648.8M | $599.0M |
净利润BMRNPLAY
| Q4 25 | $-46.6M | $-42.1M | ||
| Q3 25 | $-30.7M | $11.4M | ||
| Q2 25 | $240.5M | $21.7M | ||
| Q1 25 | $185.7M | $9.3M | ||
| Q4 24 | $124.9M | $-32.7M | ||
| Q3 24 | $106.1M | $40.3M | ||
| Q2 24 | $107.2M | $41.4M | ||
| Q1 24 | $88.7M | $36.1M |
毛利率BMRNPLAY
| Q4 25 | 68.5% | 85.8% | ||
| Q3 25 | 82.0% | 86.3% | ||
| Q2 25 | 81.8% | 85.5% | ||
| Q1 25 | 79.7% | 85.5% | ||
| Q4 24 | 81.8% | 85.0% | ||
| Q3 24 | 74.7% | 85.3% | ||
| Q2 24 | 81.7% | 85.2% | ||
| Q1 24 | 80.7% | 84.1% |
营业利润率BMRNPLAY
| Q4 25 | -5.1% | -3.6% | ||
| Q3 25 | -6.0% | 9.5% | ||
| Q2 25 | 33.5% | 11.1% | ||
| Q1 25 | 30.0% | 8.3% | ||
| Q4 24 | 21.6% | 1.4% | ||
| Q3 24 | 15.3% | 15.2% | ||
| Q2 24 | 16.9% | 14.5% | ||
| Q1 24 | 13.6% | 14.9% |
净利率BMRNPLAY
| Q4 25 | -5.3% | -9.4% | ||
| Q3 25 | -4.0% | 2.0% | ||
| Q2 25 | 29.1% | 3.8% | ||
| Q1 25 | 24.9% | 1.7% | ||
| Q4 24 | 16.7% | -7.2% | ||
| Q3 24 | 14.2% | 7.2% | ||
| Q2 24 | 15.1% | 7.0% | ||
| Q1 24 | 13.7% | 6.0% |
每股收益（稀释后）BMRNPLAY
| Q4 25 | $-0.22 | $-1.22 | ||
| Q3 25 | $-0.16 | $0.32 | ||
| Q2 25 | $1.23 | $0.62 | ||
| Q1 25 | $0.95 | $0.32 | ||
| Q4 24 | $0.65 | $-0.84 | ||
| Q3 24 | $0.55 | $0.99 | ||
| Q2 24 | $0.55 | $0.99 | ||
| Q1 24 | $0.46 | $0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.3B | $13.6M |
| 总债务越低越好 | — | $1.6B |
| 股东权益账面价值 | $6.1B | $130.8M |
| 总资产 | $7.6B | $4.1B |
| 负债/权益比越低杠杆越低 | — | 12.17× |
8季度趋势，按日历期对齐
现金及短期投资BMRNPLAY
| Q4 25 | $1.3B | $13.6M | ||
| Q3 25 | $1.3B | $12.0M | ||
| Q2 25 | $1.2B | $11.9M | ||
| Q1 25 | $1.0B | $6.9M | ||
| Q4 24 | $942.8M | $8.6M | ||
| Q3 24 | $675.4M | $13.1M | ||
| Q2 24 | $972.1M | $32.1M | ||
| Q1 24 | $747.0M | $37.3M |
总债务BMRNPLAY
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | — | $1.6B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.3B |
股东权益BMRNPLAY
| Q4 25 | $6.1B | $130.8M | ||
| Q3 25 | $6.1B | $166.2M | ||
| Q2 25 | $6.0B | $146.8M | ||
| Q1 25 | $5.8B | $145.8M | ||
| Q4 24 | $5.7B | $226.6M | ||
| Q3 24 | $5.4B | $284.4M | ||
| Q2 24 | $5.3B | $292.5M | ||
| Q1 24 | $5.1B | $251.2M |
总资产BMRNPLAY
| Q4 25 | $7.6B | $4.1B | ||
| Q3 25 | $7.6B | $4.1B | ||
| Q2 25 | $7.5B | $4.1B | ||
| Q1 25 | $7.1B | $4.0B | ||
| Q4 24 | $7.0B | $3.9B | ||
| Q3 24 | $6.9B | $3.8B | ||
| Q2 24 | $7.1B | $3.8B | ||
| Q1 24 | $6.9B | $3.8B |
负债/权益比BMRNPLAY
| Q4 25 | — | 12.17× | ||
| Q3 25 | — | 9.57× | ||
| Q2 25 | — | 10.98× | ||
| Q1 25 | — | 10.45× | ||
| Q4 24 | — | 6.58× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | 4.58× | ||
| Q1 24 | — | 5.33× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $99.6M | $58.0M |
| 自由现金流经营现金流 - 资本支出 | $58.9M | $-20.6M |
| 自由现金流率自由现金流/营收 | 6.7% | -4.6% |
| 资本支出强度资本支出/营收 | 4.7% | 17.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $725.0M | $-195.6M |
8季度趋势，按日历期对齐
经营现金流BMRNPLAY
| Q4 25 | $99.6M | $58.0M | ||
| Q3 25 | $368.7M | $34.0M | ||
| Q2 25 | $185.3M | $95.8M | ||
| Q1 25 | $174.4M | $108.9M | ||
| Q4 24 | $185.6M | $-7.2M | ||
| Q3 24 | $221.5M | $101.8M | ||
| Q2 24 | $118.8M | $108.8M | ||
| Q1 24 | $47.0M | $97.2M |
自由现金流BMRNPLAY
| Q4 25 | $58.9M | $-20.6M | ||
| Q3 25 | $340.2M | $-55.2M | ||
| Q2 25 | $168.2M | $-58.8M | ||
| Q1 25 | $157.6M | $-61.0M | ||
| Q4 24 | $166.1M | $-138.4M | ||
| Q3 24 | $203.0M | $-14.3M | ||
| Q2 24 | $97.4M | $-4.2M | ||
| Q1 24 | $20.9M | $-25.4M |
自由现金流率BMRNPLAY
| Q4 25 | 6.7% | -4.6% | ||
| Q3 25 | 43.8% | -9.9% | ||
| Q2 25 | 20.4% | -10.4% | ||
| Q1 25 | 21.2% | -11.4% | ||
| Q4 24 | 22.2% | -30.6% | ||
| Q3 24 | 27.2% | -2.6% | ||
| Q2 24 | 13.7% | -0.7% | ||
| Q1 24 | 3.2% | -4.2% |
资本支出强度BMRNPLAY
| Q4 25 | 4.7% | 17.5% | ||
| Q3 25 | 3.7% | 16.0% | ||
| Q2 25 | 2.1% | 27.2% | ||
| Q1 25 | 2.3% | 31.8% | ||
| Q4 24 | 2.6% | 29.0% | ||
| Q3 24 | 2.5% | 20.8% | ||
| Q2 24 | 3.0% | 19.2% | ||
| Q1 24 | 4.0% | 20.5% |
现金转化率BMRNPLAY
| Q4 25 | — | — | ||
| Q3 25 | — | 2.98× | ||
| Q2 25 | 0.77× | 4.41× | ||
| Q1 25 | 0.94× | 11.71× | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | 2.09× | 2.53× | ||
| Q2 24 | 1.11× | 2.63× | ||
| Q1 24 | 0.53× | 2.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BMRN
| VOXZOGO | $273.4M | 31% |
| VIMIZIM | $205.5M | 24% |
| PALYNZIQ | $125.3M | 14% |
| NAGLAZYME | $120.2M | 14% |
| Other | $49.4M | 6% |
| ALDURAZYME | $49.4M | 6% |
| KUVAN | $23.3M | 3% |
| Royalty And Other | $15.2M | 2% |
| ROCTAVIAN | $12.8M | 1% |
PLAY
| Game Play Credit Usage | $273.1M | 61% |
| Food And Nonalcoholic Beverages | $115.1M | 26% |
| Alcoholic Beverage | $53.7M | 12% |
| Other Entertainment | $6.3M | 1% |
| Gift Card Revenue | $3.5M | 1% |
